Toripalimab Based Induction Chemotherapy Followed by De-escalation Protocols in HPV-related OPSCC

NCT04867330 · clinicaltrials.gov ↗

NA

Phase

UNKNOWN

Status

46

Enrollment

OTHER

Sponsor class

Conditions

Oropharyngeal Carcinoma
Immune Checkpoint Inhibitor
De-escalation

Interventions

OTHER: Toxicities reduced treatment arm

Sponsor

Fudan University